Defence, Security, Energy, Utilities, Finance, Pharmaceuticals
Home > Pharmaceuticals > UK

Advances and Progress in Drug Design

15th February to 16th February 2016, London, United Kingdom

Overview

Open/Close

SMi’s 15th Annual Drug Design Conference will bring greater focus on enabling biophysical techniques in protein-based drug discovery, with a leading keynote address from Pfizer and Inflectis Bioscience reviving covalent drug design with opportunities in cancer treatment and quality control of misfolded proteins through small molecule inhibitors.

What are the challenges in modelling complex protein structures? How are PPI and molecular recognition quantified and translated? What new mechanistic understanding can this potenially bring to further drug design? Join the panel discussions regarding challenges accounting for protein stability, enthlapy/entropy of water, solvability and conformational changes.



 

Benefits of Attending

Open/Close

Featured Speakers

Open/Close

Who Should Attend

Open/Close